Search our applications database:

Loading
applications > All applications
300
Verifying SPARCL performance on the CLARIOstar® equipped for reading at time of injection

Mark Cameron, LUMIGEN, and Carl Peters, BMG LABTECH Inc.

11/2016

298
Real-Time Detection of Gs and Gi Signaling in Living Cells

Paul Tewson, Scott Martinka, Shane Tillo, Thom Hughes, Anne Marie Quinn, Montana Molecular, Bozeman, MT, USA; Carl Peters, BMG LABTECH Inc., NC, USA

07/2016

297
Monitoring of insulin granule packaging in live cells using homoFRET-FP detection

N.Y. Yi(1), Q. He(1), T.B. Caligan(1), G.R. Smith(1), L.J. Forsberg(2), J.E. Brenman(2) and J. Z. Sexton(1)
1 North Carolina Central University, Durham, NC
2 UNC Chapel Hill School of Medicine, Chapel Hill, NC

07/2016

296
High Throughput, Kinetic Protein Unfolding Assays Developed on the POLARstar® Omega Microplate Reader

Qiang Wang, Zoey Sharp, Nicklas Waterhouse, Matt Dominguez, and Elliott J. Stollar, Dept. of Physical Sciences, Eastern New Mexico University, USA

05/2016

295
Cellular and biochemical HTRF® assays measured in 1536-well microplates

Franka Maurer, BMG LABTECH GmbH, Ortenberg, Germany; Thomas Roux, Fanny Plénière and Najim Douayry, Cisbio Bioassays, Codolet, France

05/2016

294
Development of a Rapid HTRF Insulin Assay

Z.J. Farino(1), T.J. Morgenstern(1), J. Vallaghe(2), N. Gregor(2), P. Donthamsetti(1), P.E. Harris(1), N. Pierre(2), R. Freyberg(3), F. Charrier-Savournin(2), J.A. Javitch(1), and Zachary Freyberg(1)
1 Columbia University, NY
2 Research Dept., Cisbio Assays, France
3 Yeshiva University, NY

04/2016

293
Moss cells as expression system for biopharmaceuticals

Nicola Krieghoff and Benjamin Fode, Greenovation Biotech GmbH, Germany; Franka Maurer, BMG LABTECH GmbH, Ortenberg, Germany

03/2016

292
Lysine deacetylase activity monitored by a fluorogenic assay using the CLARIOstar®

M. Rajaee, T. Ekblad, and H. Schüler, Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden

03/2016

291
PHERAstar® FSX certified for Transcreener® Assays

Franka Maurer, BMG LABTECH GmbH, Ortenberg, Germany, and Meera Kumar, BellBrook Labs, USA

02/2016

290
Real-time measurement of intracellular O2 in mammalian cells

Franka Maurer, BMG LABTECH, Germany and Conn Carey, Luxcel Biosciences, Cork, Ireland

02/2016

289
ProteaseTag™ Active NE Immunoassay: A Rapid Test to Quantify Neutrophil Elastase Levels in Patients

Oliver Carney, BMG LABTECH Ltd, Aylesbury, UK; Kelly Moffitt and Charlene Robb, ProAxsis, Belfast, Northern Ireland

02/2016

288
Competitive bead-based fluorescence assay to quantify antibody concentration

Christine Wosnitza, Sebastian Giehring, PAIA Biotech GmbH, Cologne, Germany; Franka Maurer BMG LABTECH GmbH, Ortenberg, Germany

12/2015

287
NanoBRET™ assay for monitoring of ligand binding to GPCRs in live cells, using the CLARIOstar® and the PHERAstar FS

Leigh A. Stoddart(1), Elizabeth K. M. Johnstone(2,3), Amanda J. Wheal(1), Joëlle Goulding(1), Matthew B. Robers(4), Thomas Machleidt(4), Giovanni Abbenante(5), Keith V. Wood(4), Stephen J. Hill(1-3), and Kevin D. G. Pfleger(2,3)
1 Cell Signalling Research Group, School of Life Sciences, The University of Nottingham Medical School, Nottingham, United Kingdom.
2 Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.
3 Centre for Medical Research, The University of Western Australia, Crawley, Western Australia, Australia.
4 Promega Corporation, Madison, Wisconsin, United States.
5 BMG LABTECH Pty Ltd, Mornington, Victoria, Australia.

09/2015

286
Detection of human tau protein aggregation

Delphine Jaga, Cisbio Bioassays, France, and Franka Maurer, BMG LABTECH, Germany

09/2015

284
Monitoring receptor ligand binding in living cells

Dominik Schelshorn, Geneva Biotech, Switzerland, and Franka Maurer, BMG LABTECH, Germany

07/2015

282
Using SPARCL technology to Develop Immunoassays for Biomarker Detection and Pharmacokinetic Studies

Wenhua Xie, Mark Cameron, Lumigen, Southfield, MI; Carl Peters, BMG LABTECH, Cary, NC

06/2015

281
Detecting Mycoplasma Cell Culture Contamination Using the CLARIOstar® Microplate Reader

Jacob Serfass and Megan Young, Penn State Hershey College of Medicine; Carl Peters, BMG LABTECH, Cary, NC

05/2015

280
The OxiSelect Cellular Antioxidant Assay (CAA) on the FLUOstar Omega

Hanaa Yamani, School of Applied Science Biotechnology and Environmental Biology, RMIT University, Melbourne, Australia and Giovanni Abbenante, BMG LABTECH Australia

05/2015

279
Miniaturization of an HTRF Methyltransferase Assay that Detects Histone Modifying Activity

Bonnie Edwards, Labcyte, Sunnyvale, CA and Carl Peters, BMG LABTECH, Cary, NC

04/2015

278
The new Atmospheric Control Unit (ACU) for the CLARIOstar® provides versatility in long term cell-based assays

Carl Peters, BMG LABTECH, Cary, NC; Tracy Worzella, Promega, Madison, WI

02/2015

277
Authentication and Quality Testing of Distilled Spirits Using the SPECTROstar Nano

Gary Spedding, Brewing and Distilling Analytical Services, LLC, Lexington, KY, USA; Carl Peters, BMG LABTECH, Cary, NC, USA

01/2015

268
LanthaScreen® TR-FRET tyrosine kinase and protein kinase C assay

Randy Hoffman, Megan Buros, Kevin Kupcho, Invitrogen Corporation; E.J. Dell, BMG LABTECH

12/2014

260
Miniaturization of a Cell-based TNF-α AlphaLISA® Assay Using Echo® Liquid Handler and the PHERAstar FS

Carl Peters, BMG LABTECH, Cary, NC, USA; Bonnie Edwards, Labcyte, Sunnyvale, CA, USA

12/2014

258
Detection of PARP-induced ADP-ribosylation using the CLARIOstar® microplate reader

A. Thorsell, A. Pinto, T. Ekblad and H. Schüler
Karolinska Institute, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden

10/2014

257
Looking for a strong promoter for Physcomitrella patens

Lucas Schneider(1), Manuel Hiss(1), Stefanie Tintelnot(2), Stefan A. Rensing(1)
(1)University of Marburg, Faculty of Biology
(2) BMG LABTECH, Ortenberg, Germany

11/2014

256
Protein-Ligand binding measurements using fluorescence polarization

Valentina Speranzini(1), Alexander Fish(2) and Andrea Mattevi(1)
(1) Lab of Structural Biology, University of Pavia, Dept. Biology and Biotechnology, Italy
(2) Division of Biochemistry and Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands

10/2014

255
Detecting Sclerostin-LRP5/6 interaction using the CLARIOstar® and LVF-Monochromator

Carl Peters, BMG LABTECH, Cary, NC; Courtney Noah, Enzo Life Sciences, Farmingdale, NY

09/2014

253
Real time calcium flux measurements in iPSC derived 3D heart tissues

Michael Conway and Tetsuro Wakatsuki, InvivoSciences, Madison, WI

08/2014

252
Real-time monitoring of genetically encoded redox probes in mammalian cell monolayers

Daria Ezeriņa, Bruce Morgan, Tobias P. Dick, Division of Redox Regulation, German Cancer Research Centre (DKFZ), Heidelberg, Germany

05/2014

251
Identification of novel haemoglobin-modifying activity in snake venom libraries using the PHERAstar FS

Paul Hayter, Steven Trim, Venomtech Ltd., UK; Anthony Baines, University of Kent, UK; Lorraine Croucher, Catherine Wark, BMG LABTECH UK

05/2014

250
Following Abeta fibrillization/aggregation in real-time using a FLUOstar Omega microplate reader

Frank Baumann, Hertie Institute for Clinical Brain Research, Tübingen, Germany

12/2014

249
Assessing Epigenetic Enzyme Activity using HTRF® Epigenetic Assays from Cisbio with the PHERAstar FS from BMG LABTECH

Thomas Roux, Rebecca LaRose, Cisbio, Bedford, MA; Carl Peters, BMG LABTECH, Cary, NC

248
Measuring Mitochondrial Function and Glycolytic Flux in 3D cell cultures

Conn Carey & James Hynes, Luxcel Biosciences, Ireland

09/2014

247
Screening for Histone Deacetylase (HDAC) Active Compounds

Franka Maurer, BMG LABTECH GmbH, Ortenberg, Germany; Sheraz Gul and Gesa Witt, European ScreeningPort GmbH, Hamburg, Germany

12/2013

245
Fluorescence Intensity Transcreener® assay used to detect ADP on the CLARIOstar®

Mark Gröne, Franka Maurer, BMG LABTECH, Ortenberg, Germany

06/2013

244
The CLARIOstar® surpasses the certification needed for the Transcreener® ADP2 FP assay

Franka Maurer, BMG LABTECH, Ortenberg, Germany; Meera Kumar, Bellbrook Labs, Madison, WI, USA

09/2013

243
Dual Luciferase Reporter (DLR) Assay Certification on the PHERAstar FS

Carl Peters, Ph.D., BMG LABTECH, Cary, NC

07/2013

242
Low-volume protein measurements (280nm): Validating the LVis Plate over many concentrations

Sarfaraj Topia, Alison Turner, UCB Pharma, Bath Road, Slough, UK

07/2013

241
Molecular Beacon based helicase assays on the FLUOstar Omega

Alicia M. Hanson and David N. Frick, Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI; Carl Peters, BMG LABTECH, Cary, NC

06/2013

240
A high-throughput, homogeneous, FRET-based assay to detect bacterial membrane-bound enzyme (MraY) activity

Adam B. Shapiro, AstraZeneca R&D Boston, MA; Carl Peters, BMG LABTECH, Cary, NC

07/2013

238
96-Well Nephelometric Assay to Detect Calcification Propensity of Serum Samples

A. Pasch, Department of Nephrology, Hypertension and Clinical Pharmacology, University Hospital and University of Bern, Bern, Switzerland; W. Jahnen-Dechent, Zell- und Molekularbiologie an Grenzflächen, RWTH Universitätsklinikum Aachen, Germany

07/2013

236
Identification and characterisation of novel positive allosteric modulators of the Galanin 2 Receptor

Hayley Jones, Jeff Jerman, MRC Technology, London; David Wynick, University of Bristol, Bristol, UK; Catherine Wark, Carl Peters, BMG LABTECH, Cary, NC

06/2013

235
Three assays in one well: Antimalarial compound library screening using the FLUOstar Omega

Sheena McGowan, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia

03/2013

234
Real-time fluorescence assay for monitoring transglutaminase activity

Magdalena Adamczyk, Andreas Heil, Daniel Aeschlimann, Matrix Biology & Tissue Repair Research Unit, School of Dentistry, Cardiff University, Heath Park, Cardiff, CF14 4XY, UK

04/2013

233
Simultaneous dual-emission detection of luciferase reporter assays

Megan Dobbs B.S., Douglas Hughes Ph.D., Janaki Narahari Ph.D., Jae Choi Ph.D., Georgyi Los Ph.D., Brian Webb Ph.D., Thermo Fisher Scientific, Rockford, IL; Eric Matthews M.S., Carl Peters Ph.D., BMG LABTECH, Cary, NC

03/2013

232
Real-Time Quaking Induced Conversion Assay for Prion Seeding

Maggie Nakamura, BMG LABTECH, Cary, NC

12/2012

231
Label-Free Kinetic Measurements Using SoPRano™ Gold Nano Rods (GNRs) and a Spectrometer Microplate Reader

Meike Roskamp, Jessika Meuvis, PharmaDiagnostics, Zellik, Belgium; David Myszka, Biosensor Tools, Utah, USA; E.J. Dell, BMG LABTECH, GmbH, Ortenberg, Germany

09/2012

230
Label-Free SoPRano™ Gold Nano-Rod (GNR) Assays on a Spectrometer-Based Microplate Reader

E.J. Dell, BMG LABTECH, GmbH, Ortenberg, Germany; Meike Roskamp, Frederik Van de Velde, PharmaDiagnostics, Zellik, Belgium

06/2012

229
Nano High-Throughput Screening (nHTS) Platform - Miniaturization of Cell-based GPCR and Kinase Assays

E.J. Dell, BMG LABTECH, North Carolina, US; Sunitha Sastry, DiscoveRx, Freemont, US; Bonnie Edwards and Jing Wang, Labcyte Inc, Sunnyvale, US

12/2012

228
Biocolor's APOPercentage Apoptosis Assay™ on BMG LABTECH's SPECTROstar Nano plate reader

J.C. Morrow, D. Steele, Biocolor Ltd. 8, Meadowbank Road, Carrickfergus, Co. Antrim, N. Ireland, BT38 8YF

09/2012

227
Quantifying Fluorescent Ligand Binding to GPCRs in Live Cells using the PHERAstar FS - a new format for HTS

Alison Carter, Kevin Thompson, CellAura Technologies Ltd, Nottingham, UK; Catherine Wark, BMG LABTECH, Aylesbury, UK

06/2012

226
A New Way to Test the Free Amino Nitrogen Content in Alcoholic Beverages with the SPECTROstar Nano

Gary Spedding, Nathan R. Harrison, Brewing and Distilling Analytical Services, LLC, Lexington, USA; Franka Ganske, EJ Dell, BMG LABTECH, Ortenberg, Germany

05/2012

225
Methyltransferase, Acetyltransferase, Kinases, and GTPases Can All Be Measured with Transcreener® Assays

Meera Kumar, Tom Zielinski, Andrew Koop, BellBrook Labs, Madison, WI, USA; Franka Ganske, E. J. Dell, BMG LABTECH Inc., Cary, NC, USA

05/2012

224
Assessing pancreatic trypsin activity using the POLARstar Omega Microplate Reader

W. Huang, M. C. Cane, D. Latawiec, M. Awais, J. Armstrong, M. Chvanov, D. N. Criddle, R. Sutton, Liverpool NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, University of Liverpool, L69 3GA, UK

05/2012

223
Real-time Monitoring of Intracellular Oxygen Using MitoXpress®-Intra

James Hynes, Conn Carey, Luxcel Biosciences Ltd, Ireland; Catherine Wark, BMG LABTECH Ltd., UK

03/2012

222
HTS Instrument Discovers Low Affinity Inhibitors of the Inositol Phosphate (IP) Signaling Pathway

E.J. Dell, BMG LABTECH GmbH, Ortenberg, Germany; J.L. Tardieu, F. Degorce, Cisbio Bioassays, Codolet, France

02/2012

221
Monitoring Intracellular cAMP with hMSC cAMP biosensor using the LUMIstar Omega

K. Atze, B. Ortmann, S. Valentin, M. Kühn, S. Franke, N. Breuer, L. de Bruin, A. Pitt, Lonza Cologne GmbH, Cologne, Germany; P. Stecha, B. Binkowski, Promega Corporation, Madison, WI 53711 USA

01/2012

220
A Fluorescence Based Assay of the Epigenetic Enzyme Histonedeacetylase 1 (HDAC1)

Patricia Haus, Franz-Josef Meyer-Almes, University of Applied Science, Darmstadt, Germany

02/2012

219
Assessment of Extracellular Acidification using a Fluorescence-Based Assay

James Hynes, Conn Carey, Sinead Kriwan, Luxcel Biosciences Ltd., Cork, Ireland; Catherine Wark, BMG LABTECH Ltd., Aylesbury, UK

10/2011

218
BlueScreen HC - A Luminescence Based, High-Throughput, In Vitro Genotoxicity Assay

Andrew Knight, Chris Hughes, Matthew Tate, Gentronix Limited, Manchester, UK

08/2011

217
Growth of Campylobacter using BMG LABTECH s FLUOstar Omega equipped with ACU

R. D. Haigh, J. M. Ketley, Department of Genetics, University of Leicester, Leicester, LE1 7RH

08/2011

216
Monitoring Intracellular Ca2+ Fluxes with Clonetics™ primary sensors using the LUMIstar Omega

Bodo Ortmann, Silke Valentin, Kristin Atze, Nadine Breuer, Steffi Franke, Mathias Kühn, Leon de Bruin, Lonza Cologne GmbH, Nattermannallee 1, 50829 Cologne, Germany

06/2011

215
Miniaturised Platelet Aggregation Assays using the NOVOstar Microplate Reader

Sakthivel Vaiyapuri, Jonathan M Gibbins, Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Whiteknights, Reading RG6 6UB

04/2011

214
Quantitative, High- Throughput, Fluorescent-Based Bioassay to Detect Schistosoma Viability

Emily Peak, Iain W. Chalmers, Karl F. Hoffmann, Aberystwyth University, UK

03/2011

213
The ELISAONE™ assay performed on the POLARstar Omega from BMG LABTECH

Miriam Uppill, Antony Sheehan and Ron Osmond, TGR BioSciences Pty Ltd

03/2011

212
Promotion of Aggregation as a Means of Assessing the Stability of Antibody Molecules

Alison Turner, UCB (Celltech), 216 Bath Road, Slough,SL1 4EN, UK

02/2011

211
Measure femtogram quantities of dsDNA on the BMG LABTECH PHERAstar Plus

Ben Ferneyhough, Nick Parkinson, SBL UK, Abingdon, UK

01/2011

210
An AlphaScreen® SureFire® Phospho-ERK1/2 assay performed on BMG LABTECH's POLARstar Omega

J.D. Brown, R. Mould, C.J. Langmead, Department of Pharmacology, Heptares Therapeutics, Welwyn Garden City, UK

01/2011

209
GPCR Activation is Measured with Cisbio’s cAMP and IP-One HTRF® HTplex™ Cell-based Assay

Laurence Jacquemart, Cisbio Bioassays; E.J. Dell, BMG LABTECH

10/2010

208
A Fast and Simple Method For Measuring P-Glycoprotein (Pgp) Inhibition

Donald L. Melchior, The Fluorosome Company, Worcester, MA 01605, USA; Frances J. Sharom, Department of Molecular and Cellular Biology, University of Guelph, Guelph ON Canada N1G 2W1; E.J. Dell, BMG LABTECH, 13000 Weston Parkway, Cary NC 27513, USA

04/2010

207
Assessing Microbial Metabolism Using A Simple ‘Mix & Measure’ Oxygen Consumption Assay

James Hynes, Conn Carey, Luxcel Biosciences Ltd., Cork, Ireland; Catherine Wark, BMG LABTECH Aylesbury, UK

05/2010

206
Cellular Dopamine and Intracellular Calcium Signaling Using the Next Generation HTS Microplate Reader

Mark Koeppel, Invitrogen, Madison Wisconsin, USA; EJ Dell, BMG LABTECH, NC, USA

02/2010

205
Membrane Fluidity Measurements Using UV Fluorescence Polarization and the POLARstar Omega

Yulia Kushnareva, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA; EJ Dell, BMG LABTECH Inc., NC, USA

12/2009

204
Analysis of migration using the Oris(TM) Cell Migration Assay-TriCoated kit on the POLARstar Omega

Iman van den Bout, Inositide Laboratory, Paterson Institute for Cancer Research, Manchester, UK

11/2009

203
Enzyme Kinetic Measurements for a Combinatorial Library of Inhibitors of Pseudomonas Elastase

George Cathcart, Brendan Gilmore, Brian Walker, School of Pharmacy, QUB, Belfast

10/2009

202
Promega's ADP-Glo™ Kinase Assay performed on BMG LABTECH's PHERAstar FS and POLARstar Omega

Franka Ganske, BMG LABTECH Germany; EJ Dell, BMG LABTECH, NC, USA; Sarah Schultz, Promega Corp., Madison, WI, USA

12/2009

201
The Transcreener® ADP2 FI Assay performed on PHERAstar and Omega microplate readers

Franka Ganske, BMG LABTECH, Offenburg, Germany; EJ Dell, BMG LABTECH, NC, USA; Meera Kumar, BellBrook Labs, Madison, USA

11/2009

199
Monitoring Bacterial Cell-to-Cell Communication “Quorum sensing” Using FLUOstar OPTIMA

K.E. Eboigbodin, G.K. Robinson, Dept. of Biosciences, University of Kent, Canterbury, CT2 7NJ

08/2009

197
ORAC Assay Performed on the POLARstar Omega and PHERAstar FS microplate reader

Franka Ganske, Marjan Orban, BMG LABTECH GmbH

07/2009

196
Using Intrinsic Tryptophan Fluorescence to Measure Heterotrimeric G-Protein Activation

Robin E. Muller, David P. Siderovski, Adam J. Kimple, University of North Carolina, Chapel Hill, NC; EJ Dell, BMG LABTECH, Inc., Durham, USA

07/2009

195
alamarBlue® Assay for Assessment of Cell Proliferation using the FLUOstar OPTIMA

A.E. Markaki, Dept. of Engineering, University of Cambridge, Trumpington Street, Cambridge CB2 1PZ, UK

06/2009

194
FRET-based screening for potential modulators of the Gαi1 protein/GoLoco interaction

Stephanie Q. Hutsell, Adam J. Kimple, David P. Siderovski, University of North Carolina at Chapel Hill, 120 Mason Farm Road, CB#7365, Chapel Hill, NC 27599-7365

09/2009

193
Functional Screening of recombinant CHO-M1 cells using the PHERAstar from BMG LABTECH

Bernd Laffert, CCS Cell Culture Service, Hamburg, Germany; Franka Ganske, BMG LABTECH, Offenburg, Germany

05/2009

192
A DELFIA® time-resolved fluorescence cell-mediated cytotoxicity assay performed on the PHERAstar

N.M. Patterson, T. Cunningham, X. Jiang, D.J. Shapiro, University of Illinois, Urbana, IL; E.J. Dell, BMG LABTECH, Durham, NC; F. Ganske, BMG LABTECH, Germany

06/2009

191
High-Throughput Monitoring of Bacterial Growth at Elevated Hydrostatic Pressure on the FLUOstar OPTIMA

S. Lucas Black, Institute of Cell Biology, University of Edinburgh, UK & SUPA, School of Physics and Astronomy, University of Edinburgh, UK; F. Bruce Ward, Institute of Cell Biology, University of Edinburgh, UK; Rosalind J. Allen, SUPA

03/2009

190
Homogeneous IgG AlphaLISA® assay performed on BMG LABTECH’s PHERAstar Plus

Franka Ganske, BMG LABTECH, Offenburg, Germany; Keith Ansell, MRC-T, Burtonhole Lane, London, UK

03/2009

189
High-Throughput Method for Dual Assessment of Antifungal Activity and Growth Kinetics Using a FLUOstar Omega

Gordon Ramage, Ryan Quinn, Steven Milligan, Section of Infection and Immunity, Glasgow Dental School, Faculty of Medicine, University of Glasgow, Glasgow, G2 3JZ, UK

03/2009

188
A Leukocyte Adhesion Assay Performed on BMG LABTECH’s FLUOstar OPTIMA

Sanders, D.A. and Charnock-Jones, D.S., University of Cambridge Department of Obstetrics & Gynaecology, Cambridge CB2 2SW, UK

03/2009

187
Application of the Amplifluor® SNPs Genotyping System using a FLUOstar OPTIMA microplate reader

A. Hamilton, R. Liang, B. Whittle, Bioscience Genotyping and Mapping Division, The Australian National University

03/2010

185
Enzyme kinetic measurements performed on BMG LABTECH's FLUOstar OPTIMA

Franka Ganske, BMG LABTECH, Offenburg, Germany

04/2009

184
Multiplex Analysis of Inflammatory Cytokines from Primary Human Macrophages using a FLUOstar Omega

Brenda E. Mutch, Kate Willetts, Emma Timms, Brian M J Foxwell, Kennedy Institute of Rheumatology, 65 Aspenlea Road, Hammersmith, London, W6 8LH

12/2008

183
New Transcreener® ADP2 FP Assay performed on BMG LABTECH's POLARstar Omega Microplate Reader

Franka Ganske, BMG LABTECH, Offenburg, Germany; EJ Dell, BMG LABTECH, Durham, USA; Brad Larson, BellBrook Labs, Madison, USA

05/2009

182
New Transcreener® ADP2 FP Assay performed on BMG LABTECH´s PHERAstar Plus HTS Microplate Reader

Franka Ganske, BMG LABTECH, Offenburg, Germany; EJ Dell, BMG LABTECH, Durham, USA; Brad Larson, BellBrook Labs, Madison, USA

12/2008

180
High-throughput protein-DNA affinity measurements using fluorescence anisotropy

Dmitry B. Veprintsev, MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK

09/2008

179
Fluorometric determination of extracellular enzyme activities in peat using the FLUOstar OPTIMA

Bonnett, S.A.F., Leah, R., Maltby, E., Institute for Sustainable Water, Integrated Management and Ecosystem Research University of Liverpool, Merseyside, UK

09/2008

178
Reaction optimization by parallel kinetic studies with the FLUOstar Omega

James E. Redman, Cardiff University, School of Chemistry, Main Building, Park Place, Cardiff, CF10 3AT, United Kingdom

08/2008

177
HTRF® IP-One Terbium-based assay performed on BMG LABTECH´s PHERAstar Plus

Franka Ganske, BMG LABTECH, Germany; Laurence Jacquemart, Alexandre Jean, Marie-Laure Lebreton, Jean-Luc Tardieu, Cisbio Bioassays, France

09/2008

176
Rapid ultra-sensitive isothermal DNA detection using RPA technology and the POLARstar OPTIMA

Olaf Piepenburg, Niall A. Armes, TwistDX Ltd., Meditrina Building, Babraham Research Campus, CB22 3AT Cambridge, UK

08/2008

175
Measuring Mitochondrial Membrane Potential using the FLUOstar Omega Microplate Reader

Heather Mortiboys, Oliver Bandmann, Academic Neurology Unit, Medical School, University Of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK

07/2008

174
Nephelometric Monitoring Growth of Candida albicans Using BMG LABTECH’s NEPHELOstar*

U.C. Hipler, Universitätsklinikum Jena, Teilkörperschaft der Friedrich-Schiller-Universität Jena

08/2008

172
Dual luciferase assay to assess the replication of the hepatitis C virus subgenomic replicon

Sarah Gretton, Mark Harris, Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT

09/2008

171
Evaluation of PARP Inhibitors: Performed on BMG LABTECH’s FLUOstar Omega

Rebecca Foster, Kyla Grimshaw, Hypoxium Ltd, Cambridge, UK

04/2008

170
Detection of NADH and NADPH with the Omega’s High Speed, Full UV/Vis Absorbance Spectrometer

E.J. Dell, BMG LABTECH, Inc., Durham, USA; Franka Ganske, BMG LABTECH GmbH, Offenburg, Germany

05/2008

169
Old Assays, New Instrument: ELISA; NADH and NADPH Conversion; DNA and Protein Quantitation

Franka Ganske, BMG LABTECH, GmbH, Offenburg, Germany; E.J. Dell, BMG LABTECH, Inc., Durham, USA

04/2008

168
167
Comparison of Thioredoxin Activity in Cortical Neurons and Glial Cells using the FLUOstar OPTIMA

Sofia Papadia, Centre for Neuroscience Research, University of Edinburgh, Edinburgh, EH8 9XD

03/2008

166
Molecular Probes® NanoOrange® Assay Performed on BMG LABTECH FLUOstar OPTIMA Microplate Reader

Tracey Madgett, University of the West of England, Bristol Faculty of Health and Life Sciences, Frenchay Campus, Coldharbour Lane, Bristol, BS16 1QY, UK

01/2008

164
Use of the FLUOstar OPTIMA Microplate Reader to Monitor Amyloid Formation

Sarah Shammas, Ann-Christin Brorsson, Department of Chemistry and Cavendish Laboratory, University of Cambridge, UK

1/2008

163
SUMO FRET-based Assays Performed on BMG LABTECH’s NOVOstar

Sarah F. Martin, School of Physics and Astronomy, University of St. Andrews, North Haugh, St. Andrews, KY16 9SS, UK; Michael H. Tatham, College of Life Science, University of Dundee, Dow Street, Dundee, DD1 5EH, UK

1/2008

162
Investigation of the Stereoselectivity of an Anti-Amino Acid Antibody Utilizing Tryptophan Fluorescence

Danielle M. Corgliano, Heike Hofstetter, Oliver Hofstetter, Northern Illinois University, DeKalb, IL, USA

11/2007

160
High Speed FRET based SNP Genotyping Measurement on the PHERAstar

Phil Robinson, KBiosciences, Hoddesdon, Hertfordshire, EN11 0EX, UK; Franka Ganske, BMG LABTECH, Offenburg, Germany

11/2007

159
High-Throughput Method for Dynamic Measurements of Cellular Viability Using a FLUOstar OPTIMA

Mark S. Chitolie, Emil C. Toescu, Dept. of Physiology, Division of Medical Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT UK

04/2008

158
Bradford Assay Performed on BMG LABTECH´s FLUOstar Omega with new Evaluation Software

Franka Ganske, E.J. Dell, BMG LABTECH, Offenburg, Germany

08/2007

157
Calcium Detection Upon GPCR Stimulation Using the NOVOstar Microplate Reader and Screen Quest™ Fluo-8 NW Calcium Kit

Jinfang Liao, ABD Bioquest, Sunnyvale, CA, USA; E.J. Dell, BMG LABTECH Inc, Durham, NC, USA

06/2007

156
Internalisation of Fluorescently Labelled Phagocytosis Targets Quantified by the FLUOstar OPTIMA

Abigail Taylor, Louise Donnelly, Thoracic Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY.

05/2007

155
Growth of Neisseria meningitidis in the FLUOstar OPTIMA with Microprocessor Controlled Gas Vent

Kerry L. Cutter, University of the West of England, Bristol, UK

03/2007

154
Cisbio's HTRF® Cortisol assay performed on the PHERAstar

Franka Ganske, BMG LABTECH, Germany; Jean-Luc Tardieu, Francois Degorce, Cisbio International, France

03/2007

153
Detection of Tyrosine Kinase Activity Using the PHERAstar in AlphaScreen® Mode

Franka Ganske, Marjan Orban, BMG LABTECH, Offenburg, Germany

02/2007

152
Transcreener® ADP Fluorescence Polarization Assay Performed on the PHERAstar

Franka Ganske, BMG LABTECH, Offenburg, Germany; E.J. Dell, BMG LABTECH, Durham, USA; Brad Larson, BellBrook Labs, Madison, USA

08/2008

151
Promega’s P450-Glo™ Luminescent Cytochrome P450 Assay Using the FLUOstar OPTIMA

James Cali, Promega Corporation, Madison, WI, USA; E.J. Dell, BMG LABTECH, Durham, NC, USA

04/2007

148
ORAC Assay on the FLUOstar OPTIMA to Determine Antioxidant Capacity

Franka Ganske, BMG LABTECH, Offenburg, Germany; E.J. Dell, BMG LABTECH, Durham, USA

12/2006

146
Size-selective assessment of tight junction paracellular permeability using fluorescently labelled dextrans

Maria S. Balda, Karl Matter, Division of Cell Biology, UCL Institute of Ophthalmology, University College London, London, UK

1/2007

145
Plasso EpranEx™ ready to use heparin-binding plate with the FLUOstar OPTIMA plate reader

Michelle Wiles, Plasso Technology Ltd., Sheffield, UK

12/2006

144
Analysis of Prostate Tumour Cell Invasion Using BD FluoroBlok™and FLUOstar OPTIMA

Claire A. Hart, Noel W. Clarke, Michael D. Brown, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK

12/2006

143
Study of GPCR pharmacology using the DiscoveRx HitHunter™ cAMP HS assay on the FLUOstar OPTIMA

Julie M.-N. Rainard, Stewart E. Mireylees, Mark G. Darlison, School of Biomedical and Natural Sciences, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK

09/2006

142
HitHunter™ IP3 Assay for GPCR Screening using the PHERAstar

Lindy Kauffman, Sherrylyn De La Llera, DiscoveRx Corporation, Fremont, CA 94538, U.S.A; Silke Angersbach, Marjan Orban, BMG LABTECH GmbH, Offenburg, Germany

05/2006

141
ADP Hunter™ Assay for HTS of Kinase Inhibitors using the PHERAstar

Lindy Kauffman, Uyen Hguyen, DiscoveRx Corporation, Fremont, CA 94538, U.S.A; Silke Angersbach, Marjan Orban, BMG LABTECH GmbH, Offenburg, Germany

05/2006

140
High-Throughput Determination of Bacterial Growth Kinetics using a FLUOstar OPTIMA

Mark A Webber, Laura JV Piddock, Division of Immunity and Infection, University of Birmingham, Birmingham, B15 2TT, UK

05/2006

139
Promega’s Multiplexed Luciferase Reporter and Cell Viability Assays performed on the PHERAstar

Tracy Worzella, Brad Larson, Promega Corporation, Madison, WI, USA

07/2006

138
Promega’s Multiplexed Cell Viability and Apoptosis Assays performed on the PHERAstar

Tracy Worzella, Brad Larson, Promega Corporation, Madison, WI, USA

07/2006

137
HTRF® IP-One Assay Performed on the PHERAstar and RUBYstar* Plate Readers

Marjan Orban, BMG LABTECH, Germany; Francois Degorce, Jean-Luc Tardieu, Cisbio international, France

12/2005

136
LUX Biotechnology GLOWELL™ luminometry standards on the POLARstar OPTIMA

E. Perfect, P. Hickey, Lux Biotechnology Limited, Edinburgh, EH9 3JL, UK

11/2004

135
Protein Aggregation Monitoring on the FLUOstar OPTIMA Microplate Reader

Stephen Poon, Robert C. Rivers, Department of Chemistry, University of Cambridge, Lensfield road, Cambridge, CB21EW, UK.

12/2005

134
New HitHunter™ cAMP XS+ Assay for GPCR Screening Using the PHERAstar

Lindy Kauffman, Sherrylyn De La Llera, DiscoveRx Corporation, Fremont, CA 94538, USA; Marjan Orban, BMG LABTECH GmbH, Offenburg, Germany

12/2005

133
Measurement of Rheumatoid Factor by NEPHELOstar* Microplate Reader

Lisa Mack, Anne Barton, ARC-Epidemiology Unit, Stopford Building, University of Manchester, UK

08/2005

132
Development of a post-reaction derivatisation and fluorescence assay for 2-OG dependent dioxygenases

L.A. McNeill, K.S. Hewitson, C.J. Schofield, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, UK; L. Bethge, Humboldt Universität zu Berlin, Institut für Chemie, Brook-Taylor-Str.2, 12489 Berlin, Germany

02/2005

131
Cambrex PKLight™ Protein Kinase Assay on the PHERAstar Plate Reader

Andrew Paine, Lee Walker, Cambrex BioScience Nottingham Ltd, UK

10/2004

130
Cambrex Bio Science MycoAlert™ Assay on the LUMIstar plate reader

Anne Cox, Anthony Pitt, Cambrex Bio Science Nottingham Ltd, UK

10/2004

129
Use of the PHERAstar for SNP Genotyping Chemistry Development and High Throughput Production Genotyping

Phil Robinson, KBiosciences, Hoddesdon, Hertfordshire, EN11 0EX, UK

01/2006

128
High-Throughput Measurement of Protein Stability using a FLUOstar OPTIMA Microplate Reader

Jean P. Aucamp, Ana M. Cosme, Gary J. Lye and Paul A. Dalby, Dept. of Biochemical Engineering, University College London, Torrington Place, London WC1E 7JE, UK

06/2005

127
A Novel PI 3-Kinase Assay Utilising HTRF® Technology on the RUBYstar

Christine J. Rossant Jason P. Brown and Marie L. Marshall, Upstate Ltd., Cambridge, UK.

09/2004

126
PHERAstar: A Next Generation Multimode Plate Reader for Sophisticated HTS Assays

Marjan Orban, Silke Angersbach, BMG LABTECH, Germany; Randy Hoffman, Megan Buros, Invitrogen Corporation, USA

02/2005

125
Monitoring of Microbial Growth Curves by Laser Nephelometry

Marjan Orban, Silke Angersbach, BMG LABTECH, Germany; Sven Brand, Christian Rückert, Department of Genetics, University of Bielefeld, Germany

07/2004

124
Identification of False Positives in an FP (Fluorescence Polarization) Screen

Barbara Saxty, MRC Technology 1-3 Burton hole lane, Mill Hill London, NW7 1AD, UK

07/2004

123
Ion Channel Assay Development using Invitrogen’s FRET-based Voltage Sensor Probes

Randall L. Hoffman, Steve Duff, Naveeda Qadir, Invitrogen Corporation, Madison, WI 53719, USA

10/2005

122
Use of CyDye Fluors for Improved FRET Protease Assays on the POLARstar Microplate Reader

Jeanette George, Christopher Norey, GE Healthcare UK Limited, Amersham Place, Little Chalfont, Buckinghamshire, HP7 9NA, UK

05/2007

120
Simultaneous Dual Emission Detection for Fast Kinetic BRET Assays

Marjan Orban, BMG LABTECH GmbH, Germany

10/2004

119
Fluorescence Polarization Discriminates Green Fluorescent Protein from Interfering Autofluorescence

Andrew W. Knight, Gentronix Ltd., CTF Building, 46 Grafton Street, Manchester, M13 9NT.; e-mail: andrew.knight@gentronix.co.uk

06/2007

118
BRET assays performed on the FLUOstar OPTIMA

Marjan Orban, BMG LABTECH GmbH, Germany

08/2003

117
A Fully Automated Kinetic Solubility Screen in 384-well Plate Format using Nephelometry

Caroline Green, Seona McKee, Ken Saunders, Automation Team, Department of Drug Metabolism; Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent CT13 9NJ, UK

10/2004

114
Nephelometric Test for Determination of Colostrum Quality

Food Science, AgResearch, Ruakura Research Centre, Private Bag 3123, Hamilton New Zealand; BMG LabTechnologies Pty. Ltd, PO Box 469, Mount Eliza, 3930, Victoria, Australia

10/2002

112
Use of the LUMIstar to Monitor the Production of Free Radicals by Leukocytes in Diluted Blood

Symah Lateef, Paul R. Ingram, Corinne M. Spickett; Dept. of Immunology, University of Strathclyde, Glasgow

05/2007

111
Chemiluminescence Measurement of the Generation of Reactive Oxygen Species

Bernd Hipler, BMG LABTECH GmbH, Germany; Uta-Christina Hipler, Department of Dermatology, FSU Jena, Germany

05/2005

110
Promega ENLITEN Kit on the FLUOstar Galaxy and LUMIstar Galaxy

Ronald L. Earp, Ph. D., Jarrett Cheek, BMG LABTECH, USA

05/2007

108
Luminescent ABEL® Antioxidant Test Kit with PHOLASIN® for Vitamin C type antioxidants

Bernd Hipler, BMG LABTECH GmbH, Germany; Jan Knight, Knight Scientific Limited, UK

05/2005

107
Rapid functional screening at dopamine receptors by measuring intracellular calcium with the NOVOstar fluorescence reader

Barbara Hoefgen, Matthias U. Kassack, University of Bonn, Pharmaceutical Institute, Bonn, Germany

10/2002

106
Inhibitory Effect of Terbinafine on Reactive Oxygen Species (ROS) Generation by Candida albicans

U-C. Hipler, Ch. Schroeter, U. Wollina,Department of Dermatology and Allergology, Friedrich-Schiller-Universität, Jena, Germany; B. Hipler, BMG LABTECH, Germany

05/2007

105
Fluorescence analysis of reactive oxygen species by six isolates of Aspergillus Fumigatus

U-C. Hipler, U. Wollina, Department of Dermatology, Friedrich-Schiller-Universität, Jena, Germany; D. Denning, Department of Microbiology, University of Manchester, UK; B. Hipler, BMG LABTECH, Germany

10/2002

104
Intracellular Calcium Assay performed on NOVOstar Microplate Reader

Anders Heding, 7TM Pharma A/S, Rønnegade 2, 2100 Copenhagen, Denmark, DK

04/2004

103
Molecular Probes PicoGreen assay performed on BMG LABTECH POLARstar OPTIMA plate reader

Silke Angersbach, BMG LABTECH GmbH, Germany; Ronald Earp, BMG LABTECH, Inc., USA

09/2004

001
DNA measurements in low volume samples, microplates and cuvettes on the SPECTROstar Nano

Mark Gröne, Franka Ganske, BMG LABTECH, Germany; Catherine Wark, BMG LABTECH, UK; EJ Dell, BMG LABTECH, US

08/2011